European Biotech Forum 2026
2026-06-11 09:00 - 13:30 (Europe/Brussels)
EuropaBio is a proud sponsor of the European Biotech Forum 2026.

Biotechnology is becoming a decisive capability for Europe’s competitiveness, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape, uneven regulatory capacity, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech Communication II set out an initial toolbox, but fall short of an end-to-end industrial framework comparable to the US. The gap between ambition and execution remains significant. To what extent do these communications address the core challenges of Europe’s biotech sector? Where are the structural gaps that still block growth and industrial deployment?

More Info & Registration Here

Prague.bio Conference 2026
2026-09-23 08:00 - 20:00
Join our Director General Dr Claire Skentelbery at the 4th edition of Prague.bio Conference!

If you want to meet and network with biotech leaders shaping the CEE region, Prague.bio Conference 2026 is the place to be

Expect 400+ participants, partnering via the conference app, inspiring keynotes, panel discussions, hands-on workshops, and pitch & poster sessions.

More Info Here & Tickets

World Orphan Drug Congress 2026
2026-10-26 08:00 - 2026-10-28 20:00
The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases.

Join over 1,800 senior industry leaders, gain insights from 250+ expert speakers, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement and the latest breakthroughs in gene and cell therapies, the congress delivers practical insights you can apply immediately.

Network with the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more…

More Info Here
